Clinical Trial Update: Specified Drug-Use Survey of Trelagliptin Tablets "Survey on Long-term Use in Type 2 Diabetes Mellitus Patients With Severe Renal Impairment or End-stage Renal Disease"

View source ↗

Summary

Takeda completed a long-term-use survey of trelagliptin tablets in patients with Type 2 diabetes mellitus and severe renal impairment or end-stage renal disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Trelagliptin (trelagliptin)

Snippet

Sponsor: Takeda | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED | Results posted: 2024-08-23